Page last updated: 2024-11-12

bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bradykinin, 1-adamantanecarboxylic acid-Arg(0)-Hyp(3)-Thi(5,8)-Phe(7)-: bradykinin B2 receptor antagonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25078014
MeSH IDM0201224

Synonyms (12)

Synonym
b 6029
bradykinin, 1-adamantanecarboxylic acid-arginyl(0)-hydroxyprolyl(3)-thi(5,8)-phenylalanyl(7)-
aahtp-bradykinin
1-adamantanecarboxylic acid-0-arg-3-hyp-5,8-thi-7-phe-bradykinin
b-6029
b6029 cpd
138866-14-5
(n-adamantaneacetyl-d-arg(0)-hyp(3)-thi(5,8)-d-phe(7))bradykinin
bradykinin, 1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-
1-adamantanecarboxylic acid-arg(0)-hyp(3)-thi(5,8)-phe(7)-bradykinin
n2-(n-(n-(n-(n-(n-(trans-4-hydroxy-1-(1-(n2-(n2-(tricyclo(3.3.1.1(3,7))dec-1-ylcarbonyl)-d-arginyl)-l-arginyl)-l-propyl)-l-prolyl)glycyl)-3-(2-thienyl)-l-alanyl)-l-seryl)-d-phenylalanyl)-3-(2-thienyl)-l-alanyl)-l-arginine
l-arginine, n2-(n-(n-(n-(n-(n-(trans-4-hydroxy-1-(1-(n2-(n2-(tricyclo(3.3.1.1(3,7))dec-1-ylcarbonyl)-d-arginyl)-l-arginyl)-l-propyl)-l-prolyl)glycyl)-3-(2-thienyl)-l-alanyl)-l-seryl)-d-phenylalanyl)-3-(2-thienyl)-l-alanyl)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]